Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip [2]

Journal of Chemotherapy

Volumn 14, Issue 6, 2002, Pages 637-638

  Astal, Z ^a   Sharif, Fadel A ^b   Abdallah, S A ^c   Fahd, M I ^c  

^a Khan Younis Hospital Laboratory   (Palestine)

^b ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; EGYPT; ESCHERICHIA COLI; FEMALE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; URINALYSIS; URINARY TRACT INFECTION;

EID: 0036978120     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.6.637     Document Type: Letter

References (6)

1. Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents 2000; 16 (4):483-487.
2. Thomas KS, Sanders WE, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 1994; 33 (Suppl A): 9-15.
3. Rao GG. Risk factors for the spread of antibiotic-resistant bacteria. Drugs 1998; 55 (3): 323-330.
4. th ed. Mosby Year Book. USA. 1994; 168-186, 250-255.
5. Vandepitte J, El-Nageh MM, Tikhomirov E, Stelling JM, Estrela A. Guidelines for antimicrobial resistance surveillance. WHO Regional Publications, Eastern Mediterranean 1996; Series 15: 13-22.
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Eleventh Informational Supplement. Document M100-S11. Vol. 21. No. 1. NCCLS, Wayne, PA, 2001.